Effect of a retinoic acid analogue on BMP-driven pluripotent stem cell chondrogenesis

Abstract Osteoarthritis is the most common degenerative joint condition, leading to articular cartilage (AC) degradation, chronic pain and immobility. The lack of appropriate therapies that provide tissue restoration combined with the limited lifespan of joint-replacement implants indicate the need...

Full description

Bibliographic Details
Main Authors: Fabrizio E. Mancini, Paul E. A. Humphreys, Steven Woods, Nicola Bates, Sara Cuvertino, Julieta O’Flaherty, Leela Biant, Marco A. N. Domingos, Susan J. Kimber
Format: Article
Language:English
Published: Nature Portfolio 2024-02-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-024-52362-3
_version_ 1797274874916372480
author Fabrizio E. Mancini
Paul E. A. Humphreys
Steven Woods
Nicola Bates
Sara Cuvertino
Julieta O’Flaherty
Leela Biant
Marco A. N. Domingos
Susan J. Kimber
author_facet Fabrizio E. Mancini
Paul E. A. Humphreys
Steven Woods
Nicola Bates
Sara Cuvertino
Julieta O’Flaherty
Leela Biant
Marco A. N. Domingos
Susan J. Kimber
author_sort Fabrizio E. Mancini
collection DOAJ
description Abstract Osteoarthritis is the most common degenerative joint condition, leading to articular cartilage (AC) degradation, chronic pain and immobility. The lack of appropriate therapies that provide tissue restoration combined with the limited lifespan of joint-replacement implants indicate the need for alternative AC regeneration strategies. Differentiation of human pluripotent stem cells (hPSCs) into AC progenitors may provide a long-term regenerative solution but is still limited due to the continued reliance upon growth factors to recapitulate developmental signalling processes. Recently, TTNPB, a small molecule activator of retinoic acid receptors (RARs), has been shown to be sufficient to guide mesodermal specification and early chondrogenesis of hPSCs. Here, we modified our previous differentiation protocol, by supplementing cells with TTNPB and administering BMP2 at specific times to enhance early development (referred to as the RAPID-E protocol). Transcriptomic analyses indicated that activation of RAR signalling significantly upregulated genes related to limb and embryonic skeletal development in the early stages of the protocol and upregulated genes related to AC development in later stages. Chondroprogenitors obtained from RAPID-E could generate cartilaginous pellets that expressed AC-related matrix proteins such as Lubricin, Aggrecan, and Collagen II, but additionally expressed Collagen X, indicative of hypertrophy. This protocol could lay the foundations for cell therapy strategies for osteoarthritis and improve the understanding of AC development in humans.
first_indexed 2024-03-07T15:04:24Z
format Article
id doaj.art-7f0785f7ef8b40a899ff7fca232187f7
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-03-07T15:04:24Z
publishDate 2024-02-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-7f0785f7ef8b40a899ff7fca232187f72024-03-05T18:57:54ZengNature PortfolioScientific Reports2045-23222024-02-0114111410.1038/s41598-024-52362-3Effect of a retinoic acid analogue on BMP-driven pluripotent stem cell chondrogenesisFabrizio E. Mancini0Paul E. A. Humphreys1Steven Woods2Nicola Bates3Sara Cuvertino4Julieta O’Flaherty5Leela Biant6Marco A. N. Domingos7Susan J. Kimber8Division of Cell Matrix and Regenerative Medicine, School of Biological Sciences, Faculty of Biology Medicine and Health, University of ManchesterDivision of Cell Matrix and Regenerative Medicine, School of Biological Sciences, Faculty of Biology Medicine and Health, University of ManchesterDivision of Cell Matrix and Regenerative Medicine, School of Biological Sciences, Faculty of Biology Medicine and Health, University of ManchesterDivision of Cell Matrix and Regenerative Medicine, School of Biological Sciences, Faculty of Biology Medicine and Health, University of ManchesterDivision of Evolution, Infection and Genomics, Faculty of Biology, Medicine and Health, The University of ManchesterDivision of Cell Matrix and Regenerative Medicine, School of Biological Sciences, Faculty of Biology Medicine and Health, University of ManchesterDivision of Cell Matrix and Regenerative Medicine, School of Biological Sciences, Faculty of Biology Medicine and Health, University of ManchesterDepartment of Solids and Structures, School of Engineering, Faculty of Science and Engineering, University of ManchesterDivision of Cell Matrix and Regenerative Medicine, School of Biological Sciences, Faculty of Biology Medicine and Health, University of ManchesterAbstract Osteoarthritis is the most common degenerative joint condition, leading to articular cartilage (AC) degradation, chronic pain and immobility. The lack of appropriate therapies that provide tissue restoration combined with the limited lifespan of joint-replacement implants indicate the need for alternative AC regeneration strategies. Differentiation of human pluripotent stem cells (hPSCs) into AC progenitors may provide a long-term regenerative solution but is still limited due to the continued reliance upon growth factors to recapitulate developmental signalling processes. Recently, TTNPB, a small molecule activator of retinoic acid receptors (RARs), has been shown to be sufficient to guide mesodermal specification and early chondrogenesis of hPSCs. Here, we modified our previous differentiation protocol, by supplementing cells with TTNPB and administering BMP2 at specific times to enhance early development (referred to as the RAPID-E protocol). Transcriptomic analyses indicated that activation of RAR signalling significantly upregulated genes related to limb and embryonic skeletal development in the early stages of the protocol and upregulated genes related to AC development in later stages. Chondroprogenitors obtained from RAPID-E could generate cartilaginous pellets that expressed AC-related matrix proteins such as Lubricin, Aggrecan, and Collagen II, but additionally expressed Collagen X, indicative of hypertrophy. This protocol could lay the foundations for cell therapy strategies for osteoarthritis and improve the understanding of AC development in humans.https://doi.org/10.1038/s41598-024-52362-3
spellingShingle Fabrizio E. Mancini
Paul E. A. Humphreys
Steven Woods
Nicola Bates
Sara Cuvertino
Julieta O’Flaherty
Leela Biant
Marco A. N. Domingos
Susan J. Kimber
Effect of a retinoic acid analogue on BMP-driven pluripotent stem cell chondrogenesis
Scientific Reports
title Effect of a retinoic acid analogue on BMP-driven pluripotent stem cell chondrogenesis
title_full Effect of a retinoic acid analogue on BMP-driven pluripotent stem cell chondrogenesis
title_fullStr Effect of a retinoic acid analogue on BMP-driven pluripotent stem cell chondrogenesis
title_full_unstemmed Effect of a retinoic acid analogue on BMP-driven pluripotent stem cell chondrogenesis
title_short Effect of a retinoic acid analogue on BMP-driven pluripotent stem cell chondrogenesis
title_sort effect of a retinoic acid analogue on bmp driven pluripotent stem cell chondrogenesis
url https://doi.org/10.1038/s41598-024-52362-3
work_keys_str_mv AT fabrizioemancini effectofaretinoicacidanalogueonbmpdrivenpluripotentstemcellchondrogenesis
AT pauleahumphreys effectofaretinoicacidanalogueonbmpdrivenpluripotentstemcellchondrogenesis
AT stevenwoods effectofaretinoicacidanalogueonbmpdrivenpluripotentstemcellchondrogenesis
AT nicolabates effectofaretinoicacidanalogueonbmpdrivenpluripotentstemcellchondrogenesis
AT saracuvertino effectofaretinoicacidanalogueonbmpdrivenpluripotentstemcellchondrogenesis
AT julietaoflaherty effectofaretinoicacidanalogueonbmpdrivenpluripotentstemcellchondrogenesis
AT leelabiant effectofaretinoicacidanalogueonbmpdrivenpluripotentstemcellchondrogenesis
AT marcoandomingos effectofaretinoicacidanalogueonbmpdrivenpluripotentstemcellchondrogenesis
AT susanjkimber effectofaretinoicacidanalogueonbmpdrivenpluripotentstemcellchondrogenesis